Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritis.
J. Detert(Charité - Universitätsmedizin Berlin), Frank Buttgereit(German Rheumatism Research Centre), Rainer H. Straub(University Hospital Regensburg), Paula Hoff, Ingo Fietze(Humboldt-Universität zu Berlin), Thomas Penzel(Charité - Universitätsmedizin Berlin), Peter Jaehnig, Timo Gaber(Humboldt-Universität zu Berlin), Gerd R Burmester(Charité - Universitätsmedizin Berlin), T. Braun(Charité - Universitätsmedizin Berlin), Peter-Andreas Loeschmann(Pfizer (Germany)), Saskia Schellmann(German Rheumatism Research Centre), H. Bastian(Charité - Universitätsmedizin Berlin), René Dziurla(German Rheumatism Research Centre)
PubMed
January 27, 2017
Cited by 24
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k